Holen Sie sich die Stockscreener-App
13.43
0.68%
0.11
Schlusskurs vom Vortag:
$13.32
Offen:
$13.41
24-Stunden-Volumen:
2.34M
Relative Volume:
1.05
Marktkapitalisierung:
$3.82B
Einnahmen:
$1.16B
Nettoeinkommen (Verlust:
$77.95M
KGV:
49.54
EPS:
0.2711
Netto-Cashflow:
$144.80M
1W Leistung:
-8.53%
1M Leistung:
-21.67%
6M Leistung:
-16.45%
1J Leistung:
+18.05%
1-Tages-Spanne:
$13.29
$13.75
1-Wochen-Bereich:
$13.22
$14.79
52-Wochen-Spanne:
$9.53
$19.85
Sotera Health Co Stock (SHC) Company Profile
Firmenname
Sotera Health Co
Sektor
Branche
Telefon
440-262-1410
Adresse
9100 SOUTH HILLS BLVD, SUITE 300, BROADVIEW HEIGHTS
Compare SHC vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SHC
Sotera Health Co
|
13.43 | 3.79B | 1.16B | 77.95M | 144.80M | 0.2711 |
|
TMO
Thermo Fisher Scientific Inc
|
469.84 | 176.79B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
187.43 | 131.71B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
572.79 | 45.48B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.74 | 31.55B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
284.90 | 27.79B | 3.17B | 642.63M | 516.49M | 10.77 |
Sotera Health Co Stock (SHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2026-01-09 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2025-12-18 | Eingeleitet | William Blair | Outperform |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-05-05 | Hochstufung | Goldman | Neutral → Buy |
| 2024-12-06 | Eingeleitet | Goldman | Neutral |
| 2024-05-21 | Eingeleitet | Piper Sandler | Neutral |
| 2024-04-03 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-03-25 | Hochstufung | Jefferies | Hold → Buy |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
| 2023-06-26 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-23 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-01-11 | Hochstufung | Barclays | Underweight → Overweight |
| 2023-01-11 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2022-11-15 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-10-05 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-09-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-09-21 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2022-09-20 | Herabstufung | Goldman | Buy → Neutral |
| 2022-06-09 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-03-03 | Herabstufung | Jefferies | Buy → Hold |
| 2022-03-02 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-14 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-12-15 | Eingeleitet | Citigroup | Buy |
| 2020-12-15 | Eingeleitet | Credit Suisse | Outperform |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-15 | Eingeleitet | JP Morgan | Overweight |
| 2020-12-15 | Eingeleitet | Jefferies | Buy |
| 2020-12-15 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Sotera Health Co Aktie (SHC) Neueste Nachrichten
Sotera Health at Barclays Conference: Strategic Growth and Legal Challenges - Investing.com
Sotera Health Board Member Trades $229.05M In Company Stock - Benzinga
Insider Transaction: WARBURG PINCUS CO Sells $229.05M Worth Of Sotera Health Shares - Benzinga
Sotera Health Company (NASDAQ:SHC) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Sotera Health stockholders sell 25 million shares in secondary offering - Investing.com India
Sotera Health stockholders sell 25 million shares in secondary offering By Investing.com - Investing.com Canada
Sotera Health Ownership Shift As 25m Share Sale Tests Valuation - simplywall.st
Sotera Health (NASDAQ:SHC) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Wells Fargo Manages Offering for SHC - GuruFocus
Sotera Health shares fall 4.2% as private equity firms launch secondary offering By Investing.com - Investing.com South Africa
Sotera Health shares fall 4.2% as private equity firms launch secondary offering - Investing.com
Sotera Health Up 30% This Past Year, so Why Did One Fund Sell $4 Million in Shares? - AOL.com
Sotera Health (SHC) Launches 25 Million Share Secondary Offering - GuruFocus
Form 424B7 Sotera Health Co - StreetInsider
Warburg Pincus and GTCR affiliates to sell 25M Sotera Health shares - Stock Titan
SHC SEC FilingsSotera Health Co 10-K, 10-Q, 8-K Forms - Stock Titan
Sotera Health Company (SHC) Stock Analysis: Exploring a 30% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Sotera Health (SHC) Loses 13% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Finviz
Assessing Sotera Health (SHC) Valuation After Strong 2025 Results And 2026 Growth Guidance - simplywall.st
Sotera Health (SHC) Is Down 7.1% After Issuing 2026 Revenue Guidance And Marking 20th Growth Year - simplywall.st
SHC Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
SHC Should I Buy - Intellectia AI
Panel: Investors Failed To Show Sterilization Facility Owner Committed Fraud - Law360
FRAUD AND MANIPULATION—6th Cir.: Sterigenics class action dismissal affirmed by the Sixth Circuit - VitalLaw.com
Sotera Health wins appeal of investor lawsuit - Crain's Cleveland
Sotera Health is Now Oversold (SHC) - Nasdaq
Sotera Prevails in Investor Appeal of Emissions Disclosures Suit - Bloomberg Law News
Sotera Health: Strengthening Fundamentals, Margin Expansion, and Deleveraging Support Buy Rating and $20 Target - TipRanks
Sotera Health Company (NASDAQ:SHC) Q4 2025 Earnings Call Transcript - Insider Monkey
Sotera Health Company (SHC) Stock Analysis: A 16.85% Potential Upside In Healthcare Diagnostics - DirectorsTalk Interviews
Earnings call transcript: Sotera Health beats Q4 2025 EPS forecasts - Investing.com Australia
Decoding Sotera Health Co (SHC): A Strategic SWOT Insight - GuruFocus
6th Circ. Affirms Dismissal Of Sotera Toxic Gas Investor Suit - Law360
Sotera Health Q4 2025 slides: 20th year of growth, margins hit 51% - Investing.com Australia
SHC: Citigroup Maintains "Buy" Rating, Raises Price Target to $2 - GuruFocus
Sotera Health (SHC) Margin Expansion To 6.7% Tests Premium 60.9x P/E Narrative - simplywall.st
Sotera Health Co (SHC) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Market Challenges - GuruFocus
SHC Reports Strong Q4 Revenue, Exceeds Expectations - GuruFocus
SHC's Strong Q4 Revenue Surpasses Expectations with Robust Growt - GuruFocus
Sotera Health reports Q4 adjusted EPS 26c, consensus 24c - TipRanks
Sotera Health Q4 2025 slides: 20th year of growth, margins hit 51% By Investing.com - Investing.com South Africa
Sotera Health earnings beat by $0.02, revenue topped estimates - Investing.com Nigeria
Sotera Health Co reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Sotera Health beats Q4 2025 EPS forecasts By Investing.com - Investing.com Canada
Sotera Health General Counsel Alex Dimitrief to transition to outside advisor - TipRanks
Sotera Health (NASDAQ:SHC) Issues Quarterly Earnings Results - MarketBeat
Sotera Health (SHC) Announces Leadership Transition in Legal Dep - GuruFocus
SHC Projects Revenue and Earnings Growth for the Year - GuruFocus
Sotera Health Company's (NASDAQ:SHC) Q4 CY2025: Beats On Revenue - Finviz
Sotera Health (NASDAQ:SHC) Issues FY 2026 Earnings Guidance - MarketBeat
Stronger 2025 lifts Sotera Health (NASDAQ: SHC) guidance for 2026 - Stock Titan
Finanzdaten der Sotera Health Co-Aktie (SHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.05%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):